Clinical Tools

Air Quality and Contamination

Review Article: Aerobiology and Its Role in the Transmission of Infectious Diseases

Aerobiology plays a fundamental role in the transmission of infectious diseases. As infectious disease and infection control practitioners continue employing contemporary techniques, the central variables affecting the airborne transmission of pathogens are becoming better known.

AORN Comprehensive Surgical Checklist; 2016 Revised

A comprehensive Surgical Checklist based on the World Health Organization (WHO), The Joint Commission, Universal Protocol and National Patient Safety Goals.

Infection Prevention OR Case Observation Checklist

For Assessment of Infection Prevention Efforts

Methods for Measurement of Hospital OR Air Quality; 2018

Description of Airborne Particulate Cleanliness Classes and method of measurement. Aerobiotix provides particle counting free of charge.

Aerobiology Papers

Aerobiology and Infectious Disease Transmission

A. Fernstrom, M. Goldblatt, Hindawi 2012. There is a lack of industry standards for evaluating new technologies that attempt to solve the airborne particle transmission problem.


Airborne contamination of wounds in joint replacement operations

O.M. Lidwell, et al. Journal of Hospital Infection 1983. The greater part of bacterial wound contamination in total joint replacement is derived from the air.



Airborne Nosocomial Infection

T. Eickhoff, MD. Infection Control and Hospital Epidemiology, 1994. Airborne transmission appears to account for about 10% of all endemic nosocomial infections.


Air Contamination for predicting wound contamination

G. Birgand, PharmD, PhD. AJIC 2015. There is a strong correlation between air particle counts and microbial contamination, suggesting that particle counting can be used for routine evaluation of contamination in the OR ventilated with turbulent airflow or LAF.


Air Treatment Systems for controlling HAIs

W. Kowalski, PhD, HPAC Engineering 2007. The change that perhaps would have the greatest impact on nosocomial infections in this country is the establishment of national standards concerning aerobiological quality.


Economic Burden of PJI

S. Kurtz, PhD, et al. JOA 2012. Periprosthetic joint infection (PJI) is a challenging complication associated with total joint arthroplasty.


The Importance of airborne bacterial contamination of wounds

W. Whyte,et al. Journal of Hospital Infection 1982. This study revealed facts that suggest 98% of bacteria in patients’ wounds came directly or indirectly from the air.


OR Ventilation with Laminar Airflow

C. Brandt, M.D., et al. Annals of Surgery 2008. OR ventilation with laminar airflow showed no benefit and was even associated with a significantly higher risk for severe SSI after hip prosthesis.


Preventing SSI

D. Chauveaux, Ortho Traum S&R 2015. Intra-operative SSI prevention rests on a combination of multiple measures.


Prevention of airborne infection during surgery

F.H. Howorth, The Lancet, 1985. 80-90% of bacterial contaminants found in the wound after surgery come from CFUs present in the air of the OR.


Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection

Parvizi, J MD, FRCS, Gehrke, T MD, Orthopaedic Research Society 2014. Operative Environment: Consensus recognizes airborne particulate bacteria are a major source of contamination in the OR environment.



Traffic Flow in the OR

A. Andersson RN, et al. AJIC 2012. Traffic flow has a strong negative impact on the OR environment. The results of this study support interventions aimed at preventing surgical site infections by reducing traffic flow in the OR.


Ultraclean air and antibiotics for prevention of postoperative infection

O.M Lidwell, et al. Acta Orthop. Scand., 1987. The basis of the results and the incidence of joint sepsis in relation to them, recommendations have been made for standards of air contamination.



Contact Us


444 Alexandersville Rd
Miamisburg, Ohio 45342
+1 888 978 7087




Vice President of Global Sales

Jason leads our global sales team and brings over 18 years of Medical Device experience to Aerobiotix. Jason has led top performing National and Regional Sales teams, selling disruptive technology in the Cardiovascular space with Getinge, Surgical Robotics at Hansen Medical and most recently in the Biologics space with Axogen. Jason received his Bachelor of Science Degree from the University of Indianapolis.



Vice President of Global Marketing

Melissa Gietzen, MBA is a highly skilled strategic marketing professional with over 20 years’ experience in the healthcare industry. She has significant expertise in strategic planning, capital budgeting, service improvement projects, and creating strong successful brands in the orthopedic, cardiac & ophthalmology markets. Melissa holds a undergraduate degree in Management and Organization Development and a masters degree in Business Administration.



President and CEO

The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. Dr. Kirschman holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science cum laude from Colorado State University and M.D. from University of Colorado School of Medicine.

GREGORY CARROLL PH.D. Director Scientific Affairs


Director Scientific Affairs

Dr. Carroll has extensive experience in ultraviolet and photonic science. Prior to joining Aerobiotix, he led the research and development group at Sunstar Engineering. He has a Ph.D. in chemistry from Columbia University and did his postdoctoral fellowship under Nobel laureate Prof. Ben Feringa at the University of Groningen, Netherlands, and Lawrence Berkeley National Laboratory.

TONY EMBREE Chief Commercial Officer


Chief Commercial Officer

Tony leads our global sales organization and commercialization strategy. Prior joining Aerobiotix, he was Senior Manager of Strategy at Stryker. He has led sales and marketing teams in multiple organizations including SurgiCount Medical, part of Patient Safety Technologies, INC (PSTX) as it expanded from 8 hospitals in 2008 to user base of 330 hospitals at time of acquisition in 2013.

COURTNEY ADAMS, Ph.D. VP of Clinical and Medical Affairs


VP of Clinical and Medical Affairs

Dr. Adams leads our global clinical research and education initiatives as well as developing key opinion leaders to support our clinical mission. Prior to joining Aerobiotix, she held leading research and medical affairs roles at Biogen, Axogen, and MedPace. Dr. Adams holds Ph.D. in Pharmacology from University of Cincinnati.

ANTHONY DEFALCO Vice President of Engineering


Vice President of Engineering

Anthony is a topflight medical device product development engineer and leader, experienced in the development and implementation of orthopedic, environmental, and electromechanical systems.

NATHAN UTZ Vice President of Client Services


Vice President of Client Services

Nathan brings a high level of commitment to servicing and building client relations. Nathan has previously held leadership roles in the medical device industry.

MICHAEL SCHMITZ Chief Financial Officer


Chief Financial Officer

Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting. He received his BS in accounting, cum laude, from the Miami University of Ohio. Mr. Schmitz is a certified public accountant and certified management accountant.